1. Home
  2. BGC vs MANE Comparison

BGC vs MANE Comparison

Compare BGC & MANE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BGC Group Inc.

BGC

BGC Group Inc.

N/A

Current Price

$11.59

Market Cap

5.3B

Sector

Finance

ML Signal

N/A

Logo Veradermics Incorporated Common Stock

MANE

Veradermics Incorporated Common Stock

N/A

Current Price

$116.90

Market Cap

4.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BGC
MANE
Founded
1945
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.3B
4.3B
IPO Year
1999
2026

Fundamental Metrics

Financial Performance
Metric
BGC
MANE
Price
$11.59
$116.90
Analyst Decision
Buy
Strong Buy
Analyst Count
2
7
Target Price
$15.50
★ $163.50
AVG Volume (30 Days)
★ 2.6M
583.3K
Earning Date
11-05-2026
11-06-2026
Dividend Yield
★ 0.69%
N/A
EPS Growth
★ 24.00
N/A
EPS
★ 0.31
N/A
Revenue
★ $2,941,460,000.00
N/A
Revenue This Year
$22.84
N/A
Revenue Next Year
$6.44
N/A
P/E Ratio
$36.82
★ N/A
Revenue Growth
★ 29.99
N/A
52 Week Low
$8.27
$36.26
52 Week High
$12.89
$131.24

Technical Indicators

Market Signals
Indicator
BGC
MANE
Relative Strength Index (RSI) 41.09 68.48
Support Level $10.13 $92.62
Resistance Level $11.85 $130.52
Average True Range (ATR) 0.35 5.98
MACD -0.12 1.76
Stochastic Oscillator 18.73 98.37

Price Performance

Historical Comparison
BGC
MANE

About BGC BGC Group Inc.

BGC Group Inc is a brokerage and financial technology company that serves financial markets, energy, and commodities markets. Its service and product offerings include brokerage for a wide range of financial products, including fixed income, equities, commodities, derivatives, and real estate, software solutions for trading platforms, clearing, trade execution, and other back-office services. Its clients mostly include banks, financial institutions, and corporate clients. BGC operates in one reportable segment, which is providing brokerage services. Geographically, the company generates a majority of its revenue from Europe, the Middle East and Africa (EMEA), followed by the Americas and the Asia-Pacific region.

About MANE Veradermics Incorporated Common Stock

Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.

Share on Social Networks: